Caxton Associates (New York)’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$495K	Sell	1,402 -3,284	-70%	-$1.21M	0.02%	332
2024 Q3	$1.68M	Sell	4,686 -4,666	-50%	-$1.58M	0.06%	158
2024 Q2	$2.98M	Buy	+9,352	New	+$2.48M	0.1%	103
2024 Q1	–	Sell	-30,000	Closed	-$6.6M	–	590
2023 Q4	$6.6M	Buy	30,000 +29,059	+3,088%	+$6.7M	0.34%	57
2023 Q3	$213K	Buy	+941	New	+$217K	0.03%	353
2020 Q3	–	Sell	-7,013	Closed	-$849K	–	521
2020 Q2	$849K	Buy	+7,013	New	+$789K	0.07%	77
2020 Q1	–	Sell	-4,541	Closed	-$400K	–	593
2019 Q4	$400K	Sell	4,541 -2,099	-32%	-$185K	0.05%	220
2019 Q3	$530K	Buy	+6,640	New	+$535K	0.11%	118
2017 Q3	–	Sell	-2,800	Closed	-$363K	–	629
2017 Q2	$363K	Buy	2,800 +600	+27%	+$74.8K	0.01%	421
2017 Q1	$298K	Buy	+2,200	New	+$333K	﹤0.01%	349